Ten years after Hurricane Katrina devastated New Orleans, we look at the struggle to rebuild and why recovery efforts aren't spread equitably across the city.
Food scares and drug scandals have raised serious concerns over the F.D.A.’s ability to regulate effectively. A look at the resources and direction at the Food and Drug Administration, and why some are hoping for significant changes under the next administration.
- Gardiner Harris science reporter for "The New York Times"
- Rep. Rosa DeLauro U.S. Congresswoman, representing Connecticut's 3rd district; chairwoman of the Agriculture-FDA Appropriations Subcommittee
- William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
- Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
- Dr. Sidney Wolfe director of the Health Research Group at Public Citizen; editor of WorstPills.org
Most Recent Shows
Abortion opponents seek details on women who get abortions and the doctors who perform them. Several states have moved to cut Planned Parenthood funding even for clinics without abortion services. Join us to discuss new tactics in the anti-abortion movement.
For our next Readers' Review: "Go Set A Watchman." You've heard about the mystery surrounding its publication, you’ve read the reviews: Now we give you a chance to weigh in on this new release by Harper Lee.
Islamic State militants have blown up the ancient temple of Baalshamin in Palmyra and beheaded a renowned antiquities scholar. We look at recent atrocities by ISIS and the terror group’s broader strategy for power.